Loading…
Reported covered position: Staff for former Rep. Allen Boyd
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Discussing the importance of the 340B drug discount pogram and improving program oversight. Advocating for the enactment of H.R. 2674.
Advocating for passage of H.R. 2674. Extending the 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2012 · fourth_quarter · 4A
Discussing the importance of the 340B drug discount program and improving porgram oversight.
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2012 · fourth_quarter · Q4
Source: Senate LDA
Advocating for passage of H.R. 2674. Extending the 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities.
Advocating for passage of H.R. 2674. Extending the 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities.
Advocating for the passage of H.R. 2674. Extending 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities.
Advocating for the passage of H.R. 2674. Extending 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities.
Discussing the importance of the 340B drug discount program and improving program oversight.
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2012 · third_quarter · Q3
Discussing the importance of the 340B drug discount program and improving program oversight. Advocating for extension of program to the inpatient setting and repeal of the orphan drug ban.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, White House Office
2012 · second_quarter · Q2
Discussing the importance of the 340B drug discount pogram and improving program oversight. Advocating for the enactment of H.R. 2674.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2012 · first_quarter · Q1
Improving 340B program integrity. Advocating to extend the 340B drug discount program to the inpatient setting in eligible hospitals. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing orphan drug discount prohibition for certain covered entities.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2011 · fourth_quarter · RA
Advocating for passage of H.R. 2674. Extending the 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities.
Advocating for passage of H.R. 2674. Extending the 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities.
Advocating for passage of H.R. 2674. Extending the 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities.
2011 · fourth_quarter · Q4
Advocating for the passage of H.R. 2674. Extending 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
2011 · third_quarter · Q3
Advocating for the passage of H.R. 2674. Extending 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
2011 · second_quarter · RA
Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals; Improving program integrity. Preserving 340B patient definition and Medicaid reimbursement to 340B covered entities. Reversing 340B orphan drug prohibition for certain covered entities.
Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals; Improving program integrity. Preserving 340B patient definition and Medicaid reimbursement to 340B covered entities. Reversing 340B orphan drug prohibition for certain covered entities.
Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals; Improving program integrity. Preserving 340B patient definition and Medicaid reimbursement to 340B covered entities. Reversing 340B orphan drug prohibition for certain covered entities.
2011 · second_quarter · Q2
Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals; Improving program integrity. Preserving 340B patient definition and Medicaid reimbursement to 340B covered entities. Reversing 340B orphan drug prohibition for certain covered entities.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
2011 · first_quarter · 1A
Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
2011 · first_quarter · Q1
Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
2011 · first_quarter · RA
Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.